Bowel Cancer

Scientists pinpoint early 'Big Bang' of immune escape in bowel cancer evolution

7 ноября 2025 Сообщено ИИ Изображение, созданное ИИ Проверено фактами

An international team has identified an early 'Big Bang' moment in colorectal (bowel) cancer when tumor cells first evade immune surveillance, a finding that could refine who benefits from immunotherapy. The work, funded by Cancer Research UK and the Wellcome Trust, analyzed samples from 29 patients and was published in Nature Genetics on November 5, 2025.